###begin article-title 0
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Liposome-Mediated Cellular Delivery of Active gp91phox
###end article-title 0
###begin p 1
Conceived and designed the experiments: JL. Performed the experiments: BM LL MP. Analyzed the data: JL BM. Contributed reagents/materials/analysis tools: MP AV RR FM. Wrote the paper: JL BM.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Gp91phox is a transmembrane protein and the catalytic core of the NADPH oxidase complex of neutrophils. Lack of this protein causes chronic granulomatous disease (CGD), a rare genetic disorder characterized by severe and recurrent infections due to the incapacity of phagocytes to kill microorganisms.
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
Here we optimize a prokaryotic cell-free expression system to produce integral mammalian membrane proteins.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 62 66 62 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 284 288 284 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 293 297 293 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 302 306 302 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 385 389 385 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 577 581 577 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 832 836 832 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Using this system, we over-express truncated forms of the gp91phox protein under soluble form in the presence of detergents or lipids resulting in active proteins with a "native-like" conformation. All the proteins exhibit diaphorase activity in the presence of cytosolic factors (p67phox, p47phox, p40phox and Rac) and arachidonic acid. We also produce proteoliposomes containing gp91phox protein and demonstrate that these proteins exhibit activities similar to their cellular counterpart. The proteoliposomes induce rapid cellular delivery and relocation of recombinant gp91phox proteins to the plasma membrane. Our data support the concept of cell-free expression technology for producing recombinant proteoliposomes and their use for functional and structural studies or protein therapy by complementing deficient cells in gp91phox protein.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 165 166 165 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 166 169 166 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Vignais1">[1]</xref>
###xml 175 180 175 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox </sup>
###xml 257 261 257 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 295 298 295 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b<sub>558</sub></italic>
###xml 298 301 298 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Nauseef1">[2]</xref>
###xml 389 393 389 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 393 396 393 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Taylor1">[3]</xref>
###xml 569 572 565 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Wallach1">[4]</xref>
###xml 669 672 665 668 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
###xml 668 672 664 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b<sub>558</sub></italic>
###xml 678 683 674 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox </sup>
###xml 690 694 686 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 722 726 718 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 731 735 727 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 740 744 736 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 925 928 921 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Mizrahi1">[5]</xref>
###xml 1030 1031 1026 1027 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1031 1032 1027 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 74 79 <span type="species:ncbi:9606">human</span>
Gp91phox protein is the catalytic subunit of the NADPH oxidase complex in human neutrophils and is involved in the electron transfer from NADPH to molecular oxygen O2[1]. Gp91phox is a transmembrane glycoprotein which physiologically associates with the p22phox subunit to form flavocytochrome b558[2]. MALDI and nanospray LC-MS/MS methods have delineated the transmembrane domains of gp91phox[3]. This protein contains six putative alpha-helices and three extracellular loops in which the glycosylation sites (Asn132, Asn149 and Asn240) are comprised in loops 2 and 3 [4]. In its active state, NADPH oxidase is a multi-component enzyme complex composed of cytochrome b558 (gp91phox and p22phox) and cytosolic factors (p67phox, p47phox, p40phox, Rac and Rap1A) that translocate at the membrane surface from cytosol upon stimulation. From this transfer and through the assembly of the constituents, NADPH oxidase is activated [5]. Upon infection or stimulation with inflammatory mediators, NADPH oxidase from neutrophils generate O2- and then oxygen derivatives, or ROS, which are necessary for the defense of the organism.
###end p 9
###begin p 10
###xml 70 74 70 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 157 160 157 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Nisimoto1">[6]</xref>
###xml 233 237 233 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 276 280 276 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 310 314 310 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 405 408 405 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Paclet1">[7]</xref>
###xml 460 464 460 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 548 552 548 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 592 596 592 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 600 604 600 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 617 620 617 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Zhu1">[8]</xref>
Recent studies on the C-terminal part (amino acids 221 to 570) of gp91phox protein show that the cytoplasmic domain retains a high NADPH diaphorase activity [6] that can be stimulated in the presence of cytosolic proteins Rac and p67phox. This supports the hypothesis that p67phox and Rac bind directly to gp91phox and activates NADPH oxidase by inducing conformational changes in its flavoprotein domain [7]. Using a similar approach, different domains of p22phox protein have been delineated and shown to be involved in the maturation of the gp91phox protein before the assembly of the gp91phox/p22phox heterodimer [8].
###end p 10
###begin p 11
###xml 72 76 72 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 260 264 260 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 276 279 276 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Vignais1">[1]</xref>
Among these approaches, an internal domain in the N-terminal part of p22phox is involved in the flavocytochrome assembly, whereas the proline-rich region (PRR motif) in the C-terminal portion is responsible for NADPH oxidase activity via the binding to the p47phox SH3 domain [1].
###end p 11
###begin p 12
###xml 155 158 155 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Heyworth1">[9]</xref>
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBB</italic>
###xml 200 204 200 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 422 423 416 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 428 429 422 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 614 618 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Ott1">[10]</xref>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 605 613 <span type="species:ncbi:9606">patients</span>
###xml 752 759 <span type="species:ncbi:9606">patient</span>
Chronic granulomatous disease (CGD) is a rare immunodeficiency disease caused by mutations in genes encoding one of the main constituents of NADPH oxidase [9]. Mutations in the CYBB gene encoding gp91phox represent almost 60% of CGD cases. These defects largely result in a lack of protein expression (Xdegrees CGD) or, in less than 10% of CGD cases, in a decrease or a loss of oxidase activity while protein is present (X- or X+ CGD). Recently, gene therapy has been tested in animal models and in clinical trials to attempt to reconstitute NADPH oxidase activity in X-linked CGD mice or in X-linked CGD patients [10]. Although promising results have been reported, this method still employs a retrovirus that may deliver the corrective gene into the patient's genome in locations which affect essential genes such as those involved in cancer.
###end p 12
###begin p 13
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Park1">[11]</xref>
Beside gene therapy, recent progress has been made with methods for the delivery of functional proteins which are based on the direct delivery of active therapeutic proteins into targeted living cells or, in the case of monoclonal antibodies, for the stimulation of specific immune responses [11]. Different strategies are used for the delivery of functional proteins such as microinjection, electroporation, liposomes or by fusion to a protein transduction domain (PTD). Among these delivery systems, liposomes represent a promising technology for the delivery of macromolecules into cells for the following reasons: (1) they are non-cytotoxic; (2), they can deliver and specifically target a large set of bioactive molecules (such as proteins, DNA or ribozymes); (3), they can protect molecules from degradation; and (4), their composition is easily modifiable. Different studies have used liposomes for the delivery of proteins such as antigens or toxins, drugs and nucleic molecules, but none of them has attempted to deliver membrane proteins.
###end p 13
###begin p 14
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Rigaud1">[12]</xref>
###xml 439 446 439 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 682 698 682 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 722 726 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Liguori1">[13]</xref>
###xml 759 767 759 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1061 1068 1061 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1087 1091 1087 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Klammt1">[14]</xref>
###xml 1173 1180 1173 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1468 1472 1468 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Klammt2">[15]</xref>
###xml 1609 1613 1609 1613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Ishihara1">[16]</xref>
###xml 1656 1663 1656 1663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 660 666 <span type="species:ncbi:9986">rabbit</span>
###xml 682 698 <span type="species:ncbi:562">Escherichia coli</span>
###xml 711 716 <span type="species:ncbi:4565">wheat</span>
###xml 1061 1068 <span type="species:ncbi:562">E. coli</span>
###xml 1173 1180 <span type="species:ncbi:562">E. coli</span>
###xml 1621 1626 <span type="species:ncbi:9606">human</span>
###xml 1656 1663 <span type="species:ncbi:562">E. coli</span>
The production of recombinant membrane proteins by the classical overexpression systems still presents a technical challenge. Among these challenges are yield, correct folding, solubility and protein integration into the lipid membrane to constitute functional proteoliposomes [12]. However, due to their hydrophobic nature, it is difficult to make membrane proteins in a native conformation for functional and structural studies in these in vivo systems. An interesting and attractive alternative for producing membrane proteins is the use of cell-free transcription/translation systems. These cell-free protein synthesis systems are essentially derived from rabbit reticulocytes, Escherichia coli lysates, or wheat germ [13]. One of the advantages of these in vitro expression systems is their capability to synthesize cytotoxic membrane proteins, or regulatory or unstable proteins that cannot be expressed in living organisms. The efficient expression of integral membrane proteins from prokaryotic sources has recently been demonstrated by using optimized E. coli cell-free systems [14]. The modification of the reaction conditions by adding chaperones, detergents or E. coli lipids have improved the synthesis and solubility of the expressed membrane proteins. Furthermore, solubilization of precipitated membrane proteins from cell-free expression systems and the integration into synthetic lipid vesicles result in the production of functional proteoliposomes [15]. A similar approach has been attempted in the production of functional mammalian membrane proteins, G protein coupled receptors (GPCRs) [16]. Three human GPCRs were synthesized by an E. coli cell-free expression system as fusion proteins with a thioredoxin tag. After integration into phospholipid vesicles, these GPCRs proteins displayed ligand-binding activities. However, the formation of functional proteoliposomes containing GPCRs with this technology requires first solubilization in the presence of detergents, and then reconstitution into lipid vesicles through long-term dialysis. Even if this work represents an important advance in the synthesis of mammalian membrane proteins by cell-free expression technology, it cannot be applied as a general strategy for producing membrane proteins due to the large size of the thioredoxin tag (11.2kDa), which may impair the protein activity.
###end p 14
###begin p 15
###xml 128 132 128 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
In this study, we assessed the potential of the cell-free expression system to synthesize functional truncated forms of the gp91phox subunit and its capacity to directly produce proteoliposomes containing these truncated forms. We demonstrate that all the truncated forms are expressed as soluble proteins in the presence of detergents and display fully enzymatic activity. Moreover, the addition of natural lipid vesicles in the synthesis reaction results in the formation of functional proteoliposomes which can be used as vectors in the direct delivery of the membrane protein into mammalian cell lines.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 37 41 37 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
In vitro expression of truncated gp91phox
###end title 17
###begin p 18
###xml 73 77 73 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Taylor2">[17]</xref>
###xml 399 407 399 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g001">Figure 1</xref>
###xml 426 430 426 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 590 594 590 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Taylor2">[17]</xref>
An analysis of the prediction of the putative hydrophobic domains of gp91phox protein has been carried out through the use of different programs (Sosui, TMHMM, TMpred and TopPred). An alignment of the deduced transmembrane domains from these programs with the structural model published by Taylor [17] identified 6 hydrophobic domains which differ by 1 to 10 amino acids, and 3 extracellular loops (Figure 1). Analysis of gp91phox transmembrane domains by mass spectrometry has provided a more precise location of these transmembrane regions. Therefore, in this study all the generated gp91phox truncated forms are based on the structural model from Taylor [17].
###end p 18
###begin title 19
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Alignment of predicted hydrophobic domains of gp91phox.
###end title 19
###begin p 20
###xml 68 72 68 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Taylor2">[17]</xref>
This schema summarizes the different prediction of topology for gp91phox by using different programs (Sosui, TMHMM, TMpred and TopPred) or the model published by Taylor et al[17].
###end p 20
###begin p 21
###xml 42 45 42 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b<sub>558</sub></italic>
###xml 59 63 59 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 71 75 71 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Rotrosen1">[18]</xref>
###xml 307 314 307 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 463 467 463 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 576 585 576 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g002">Figure 2A</xref>
###xml 608 612 608 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 719 727 719 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 781 788 781 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 401 406 <span type="species:ncbi:9606">human</span>
###xml 781 788 <span type="species:ncbi:562">E. coli</span>
In general, the production of cytochrome b558 subunits gp91phox and p22phox through classical over-expression systems have resulted in low yields which are incompatible for further biochemical studies [18]. Recent developments suggest that cell-free expression systems represent an alternative to classical in vivo expression. In order to decipher the molecular mechanisms involved in the activity of human NADPH oxidase, we generated five truncated forms of gp91phox. Each construct contains a histidine tag located either at the N- or at the C-terminus part of the protein (Figure 2A). These truncated gp91phox proteins were first cloned into vectors dedicated to a prokaryotic expression system and then synthesized in vitro by using a transcription-translation system using an E. coli lysate.
###end p 21
###begin title 22
###xml 28 32 28 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Expression of truncated gp91phox proteins.
###end title 22
###begin p 23
###xml 84 88 84 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 148 152 148 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 340 344 340 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 486 490 486 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
(A) Schematic representation of the phagocyte NADPH oxydase and truncated forms gp91phox expressed in a bacterial cell-free translation system. Gp91phox full-length (FL) is presented at the top of the diagram: transmembrane domains are shown in black. FAD and NADPH binding-sites are represented in red and pink respectively. Truncated gp91phox were designed with a his-tag located either at the N or at the C terminal part of the protein. (B) Analysis of the expression of the ten gp91phox truncated proteins by western blot using a monoclonal antibody anti-his.
###end p 23
###begin p 24
###xml 251 260 251 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g002">Figure 2B</xref>
###xml 304 308 304 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 487 491 487 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 572 581 572 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g002">Figure 2B</xref>
###xml 669 673 669 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 707 711 707 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 755 759 755 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 770 779 770 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g002">Figure 2B</xref>
We first set up the conditions for expressing each construct in the presence or absence of chaperones or detergents. As an initial validation, the expression of these ten truncated proteins was analyzed by western blotting using an anti-his antibody (Figure 2B). Similar results were obtained with a gp91phox specific antibody (data not shown). Interestingly, the expression pattern of each construct depends on different parameters. Using the standard conditions, all the truncated gp91phox proteins are expressed but at variable levels, as detected by western blotting (Figure 2B). The position of the histidine tag may have a critical effect by decreasing (e.g. gp91phox 90-C) or by inhibiting (e.g. gp91phox 233-C) the expression of the truncated gp91phox proteins (Figure 2B). Our results suggested that the N-terminal hexa-histidine tag improves the translation efficiency either by stabilizing the messenger or by providing a better folding state of the expressed proteins.
###end p 24
###begin p 25
###xml 41 42 41 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 69 70 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 101 102 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 211 216 202 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox </sup>
###xml 332 340 323 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 774 778 762 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 822 826 810 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 854 858 839 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 870 874 855 859 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 896 900 881 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 919 928 904 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g002">Figure 2B</xref>
###xml 983 987 968 972 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1042 1046 1027 1031 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1054 1063 1039 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g002">Figure 2B</xref>
###xml 1152 1156 1137 1141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1282 1291 1267 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g002">Figure 2B</xref>
We next studied the effect of non-ionic (n-dodecyl beta-D-maltoside, n-octyl beta-D-glucopyranoside, n-thiooctyl beta-D-glucopyranoside, Nonidet P40) and zwitterionic (Chaps) detergents on the expression of gp91phox truncated forms. These detergents were selected as they are mild, relatively non-denaturing and are compatible with in vitro expression systems as they have no inhibitory effects on the expression of membrane proteins. They were all tested at their critical micellar concentration (CMC), except for Nonidet P40 (NP40), which was 100 times more concentrated than the usual CMC (0.05 mM). Interestingly, these detergents displayed various effects on protein expression. For example, Chaps and beta-OG have a strong negative effect on the expression of the gp91phox truncated forms, except for constructs gp91phox 221-C with beta-OG and gp91phox 221-C, gp91phox 233-N and 233-C, gp91phox 285-N with Chaps (Figure 2B). These two compounds decreased the expression of gp91phox 221-N, but were compatible with the expression of gp91phox 221-C (Figure 2B). In contrast, NP40, Thio-OG and DDM enhanced the expression levels for most of the gp91phox truncated forms, with a stronger effect on the constructs containing a hexa-histidine at the N-terminal part of the protein (Figure 2B). These results suggest that the addition of non-ionic detergents is compatible with the synthesis of protein in a cell-free expression system, and that this may result in an enhancement of protein synthesis.
###end p 25
###begin p 26
###xml 243 247 243 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 327 336 324 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g002">Figure 2B</xref>
###xml 461 465 458 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 489 498 486 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g002">Figure 2B</xref>
###xml 558 562 555 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
The effect of the histidine tag position on protein synthesis was also studied in the presence or absence of detergents or various compounds. Interestingly, when the histidine tag is attached to the N-terminal part of the protein, all the gp91phox truncated forms were synthesized, except in the presence of beta-OG and Chaps (Figure 2B). The other compounds (GroE and GSH/GSSG) had no effect on the expression of the truncated forms, except for constructs gp91phox 90-N, 195-N and 233-C (Figure 2B). These data indicate that the levels of expression of gp91phox truncated forms in a cell-free system depend on both the tag position and the detergent. However, there is no clear rule to determine whether a mammalian membrane protein will be expressed or not in a high yield within this optimized cell-free expression system.
###end p 26
###begin p 27
###xml 73 77 73 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 243 252 243 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g003">Figure 3A</xref>
###xml 410 414 410 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 435 439 435 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 499 503 499 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 530 534 530 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 620 624 620 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 772 776 772 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 891 895 891 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Based on these results, we sought to determine whether the truncated gp91phox proteins could be expressed under a soluble form, as this form is usually considered to possess a "native-like" conformation. The solubility tests are summarized in Figure 3A. Solubilization depends on a combination of three different factors: (1) the structural properties of the membrane protein, (2) the position of the tag (gp91phox 233-N vs. -C or gp91phox 221-N vs. -C) and (3) the detergent by itself (DDM for gp91phox 221-N/-C or Chaps for gp91phox 233-N/-C). Using the standard conditions of the cell-free expression system, the gp91phox truncated proteins were expressed as precipitates (data not shown). All the proteins were produced in a soluble form using DDM, except for the gp91phox 233 proteins which were solubilized in the presence of Chaps. Whichever compound was added, the solubility of gp91phox 90-N protein remained too low to be used for further experiments.
###end p 27
###begin title 28
###xml 31 35 31 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Solubility and activity of gp91phox recombinant proteins.
###end title 28
###begin p 29
###xml 46 50 46 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 179 183 179 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 298 302 298 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
(A) Optimization of the solubility of the gp91phox truncated proteins by western blot using a monoclonal antibody anti-his. (B) Diaphorase assay of purified soluble truncated gp91phox proteins using NBT or INT as electron acceptor. Results were expressed as moles of NBT or INT reduced/min/mol gp91phox truncated forms. Results are expressed as the average of at least two experiments+/-SD.
###end p 29
###begin title 30
###xml 43 47 43 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Diaphorase assay of purified truncated gp91phox
###end title 30
###begin p 31
###xml 77 81 77 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 203 204 203 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 204 207 204 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
###xml 234 237 234 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Paclet1">[7]</xref>
###xml 297 301 297 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Paclet2">[19]</xref>
###xml 419 425 419 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 752 756 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Cross1">[20]</xref>
###xml 831 835 831 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 419 425 <span type="species:ncbi:562">E.coli</span>
In order to investigate the functional response of the soluble truncated gp91phox proteins, it was necessary to determine whether these proteins are able to transfer electrons like the native cytochrome b558 purified from neutrophils [7]. Previous studies have shown that the glycosylation of gp91phox protein is not required for its enzymatic activity [19]. However, the production of mammalian membrane protein in an E.coli cell-free expression system results in a non-glycosylated protein. To quantify the electron transfer from NADPH to FAD, we used two different electron acceptors: NitroBlueTetrazolium (NBT), the most commonly used electron acceptor, or IodoNitroTetrazolium (INT), which has been shown to specifically accept electrons from FAD [20]. Furthermore, the existence of a diaphorase activity in the truncated gp91phox proteins would be an indicator of their correct folding status.
###end p 31
###begin p 32
###xml 101 105 101 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 185 194 185 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g003">Figure 3A</xref>
###xml 210 219 210 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000856.s001">Figure S1</xref>
###xml 293 297 293 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 527 531 527 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 536 540 536 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 545 549 545 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
In order to obtain enough soluble proteins for the functional assay, we over-expressed truncated gp91phox proteins in large scale reactions using the optimized conditions determined in Figure 3A (Supplementary Figure S1), followed by purification onto affinity chromatography. The soluble gp91phox proteins were tested for their diaphorase activity, and for each assay 10 pmoles of purified soluble protein were used. None of the truncated proteins tested exhibited activity in the absence of cytosolic regulatory proteins (p47phox, p67phox, p40phox and Rac; data not shown). By incubating the recombinant proteins with neutrophil cytosol and an optimum concentration of arachidonic acid (AA) for 10 minutes at 25degreesC, we were able to activate the recombinant proteins and to observe NADPH-dependent diaphorase activity.
###end p 32
###begin p 33
###xml 20 24 20 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 36 40 36 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 52 56 52 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 71 75 71 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 110 119 110 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g003">Figure 3B</xref>
###xml 268 272 268 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 394 403 394 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g003">Figure 3B</xref>
###xml 534 543 534 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g003">Figure 3B</xref>
###xml 676 680 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Poinas1">[21]</xref>
The results for gp91phox 195-N, gp91phox 221-C, gp91phox 233-N and gp91phox 285-N proteins are represented in Figure 3B. Their specific values of activity were 3, 6.1, 3.5 and 2.9 mol/min/mol for NBT and 4.2, 7.2, 5.3 and 3.8 mol/min/mol for INT respectively. The gp91phox 221-C protein showed an overall reductase activity which was higher for both NBT and INT compared to the other proteins (Figure 3B). For all the proteins, a diaphorase assay using INT as electron acceptor gave a higher turnover rate compared to the NBT values (Figure 3B). This could be explained by its higher specificity of electrons released by the FAD during the classical electron transfer pathway [21].
###end p 33
###begin p 34
###xml 68 72 68 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 241 245 241 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 327 328 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 328 331 328 331 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
###xml 462 466 462 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 471 475 471 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 537 541 537 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 580 589 580 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g004">Figure 4A</xref>
###xml 661 662 661 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 748 752 748 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 923 927 923 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1079 1083 1067 1071 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1091 1100 1079 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g004">Figure 4B</xref>
To confirm that the diaphorase activity measured with truncated gp91phox proteins was directly dependent on the presence of cytosolic regulatory factors, we performed the same experiment with a cytosolic fraction isolated from control or p67phox-deficient EBV-B lymphocytes. First, the diaphorase activity of native cytochrome b558 purified from neutrophils was analyzed. As expected, the electron transfer was correlated to the presence of cytosolic factors p67phox, p47phox and Rac as shown by the absence of activity measured with p67phox-deficient cytosol or without cytosol (Figure 4A). The diaphorase activity was in the range of 500-600 mol/min/mol heme b, depending on the electron acceptor used (INT or NBT). Then, the activity of the gp91phox 221-C was determined after incubation with control or deficient B lymphocyte cytosol, and arachidonic acid. The diaphorase activity was in the range of 5 mol/min/mol gp91phox 221-C with the control cytosol and was strongly and significantly decreased in presence of p67phox-deficient cytosol (approximately0.9 mol/min/mol gp91phox 221-C, Figure 4B).
###end p 34
###begin title 35
###xml 57 62 57 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox </sup>
Specificity of the diaphorase activity measured with gp91phox recombinant proteins.
###end title 35
###begin p 36
###xml 49 50 49 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 50 53 50 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
###xml 135 139 135 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 154 155 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 285 289 285 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 359 363 359 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 378 379 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
(A) Diaphorase activity measured with cytochrome b558 purified from neutrophils (10 pmol) in presence of cytosol from normal (N) or p67phox deficient (p670) EBV B lymphocytes using NBT (black bars) or INT (open bars) as electron acceptor. (B) Diaphorase activity measured with the gp91phox 221-C protein (10 pmol) in presence of cytosol from normal (N) or p67phox deficient (p670) EBV B lymphocytes using INT (open bars) as electron acceptor. Results are expressed as the mean activity of three experiments+/-SD. * indicates results significantly different (P<0.05) from the control performed in presence of normal cytosol.
###end p 36
###begin p 37
###xml 95 99 95 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 104 108 104 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 113 117 113 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 279 280 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 280 283 280 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
###xml 335 338 335 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Vignais1">[1]</xref>
###xml 384 388 384 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Taken together, these results suggested a direct interaction between the cytosolic factors (p47phox, p67phox, p40phox and Rac) and the recombinant soluble proteins, indicating an assembly of these factors and the truncated proteins as earlier described for the native cytochrome b558 during the activation of the NADPH oxidase complex [1]. Moreover, all the recombinant truncated gp91phox proteins tested were soluble and showed a specific enzymatic activity, confirming that they are in a correct and active folding state.
###end p 37
###begin title 38
###xml 28 32 28 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Expression of truncated gp91phox in the presence of lipids
###end title 38
###begin p 39
###xml 153 157 153 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 277 285 <span type="species:ncbi:9606">patients</span>
The acquisition of liposomes containing active membrane proteins is a useful tool in the study of their biochemical properties. Moreover, functional gp91phox proteoliposomes may represent an attractive delivery system for complementing NADPH activity in the neutrophils of CGD patients.
###end p 39
###begin p 40
###xml 376 382 376 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 500 504 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Rigaud1">[12]</xref>
###xml 43 50 <span type="species:ncbi:3562">spinach</span>
###xml 376 382 <span type="species:ncbi:562">E.coli</span>
In this study, we used natural lipids from spinach thylakoids. These are anionic lipids mainly composed of diacylglycerol derivatives. Usually, to obtain membrane protein inserted into a lipid vesicle, 2 steps are required: (1) extraction/solubilization/purification of the membrane protein from its natural source or from the over-expression system (i.e. inclusion bodies in E.coli) by using detergents or chaotropic agents (urea or guanidine), and (2) reconstitution into liposomes after refolding [12]. The originality of our approach results in the production of the proteoliposomes in a one-step reaction by directly adding the lipids to the reaction mixture during the synthesis.
###end p 40
###begin p 41
###xml 57 61 57 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 183 187 183 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 199 203 199 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 218 222 218 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 334 338 334 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 353 357 353 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 686 695 682 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g005">Figure 5A</xref>
###xml 735 739 731 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 804 813 800 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g005">Figure 5A</xref>
###xml 986 995 982 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g005">Figure 5A</xref>
###xml 1095 1099 1091 1095 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Firstly, our goal was to determine whether truncated gp91phox proteins could be expressed and integrated into natural lipids. We tested the expression of three membrane proteins, gp91phox 221-C, gp91phox 195-N and gp91phox 90-N containing respectively 1, 2 and 4 transmembrane domains in the presence of thylakoid lipids. For the gp91phox 221-C and gp91phox 195-N proteins, a modulation of the expression depending on the amount of lipids added during the synthesis was observed. This effect is negligible in the presence of low concentrations of lipids (</=2.5 mg/ml), but an inhibition of the expression can be observed in the presence of higher concentrations of lipids (>/=4 mg/ml, Figure 5A). Interestingly, the expression of gp91phox 90-N protein in the same conditions showed the opposite effect (Figure 5A). The addition of lipids (up to 2.5 mg/ml) enhanced its expression, and higher concentrations (>2.5 mg/ml) resulted in a slight inhibition compared to 2.5 mg/ml of lipids (Figure 5A). Based on these results, we next performed large-scale expression reactions for the construct gp91phox 221-C in the presence of 2.5 mg/ml of lipids. These proteoliposomes can be quickly and easily purified by sucrose gradient centrifugation, resulting in a purified protein which is largely integrated into the lipids vesicles (data not shown).
###end p 41
###begin title 42
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
gp91phox 221-C proteoliposomes.
###end title 42
###begin p 43
###xml 173 177 173 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 247 251 245 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 563 567 557 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 764 768 750 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 840 844 826 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1135 1137 1121 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">xz</italic>
(A) Expression of membrane protein in presence of lipids analyzed by western blot using a monoclonal antibody anti-his. (B) Diaphorase assay of purified proteoliposomes gp91phox 221-C using NBT or INT as electron acceptor, n>/=2. (C) Delivery gp91phox 221-C with proteoliposomes in HCT116 cells after 8 hours of incubation. As a negative control, cells were incubated with the same amount (0.5 microg) of empty liposomes. The proteins were detected by fluorescence microscopy using a monoclonal anti-his antibody. (D) Confocal analysis of the distribution of gp91phox 221-C protein delivered with proteoliposomes in HeLa cells after 8 hours of incubation. As a negative control, cells were incubated with 0.5 microg of empty liposomes or 0.5 microg of soluble gp91phox 221-C. Cells were labelled for the exogenous protein using an anti-gp91phox antibody (Red) and for the endogenous Clathrin (Green). The cells were examined under a Zeiss LSM510 (NLO) laser confocal microscope. The image plane was chosen to be near the equator of the cell body and nucleus. (E) Higher magnification of the white boxed area in (D) with the respective xz projections.
###end p 43
###begin title 44
###xml 24 28 24 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Diaphorase assay of gp91phox 221-C proteoliposomes
###end title 44
###begin p 45
###xml 120 124 120 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 201 205 201 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 289 293 289 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 309 318 309 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g003">Figure 3B</xref>
In order to evaluate the effect of the integration into natural lipids on the capacity to transfer electrons of the gp91phox 221-C proteins, we used purified recombinant proteoliposomes containing gp91phox 221-C protein and assessed its reductase activity as described for the soluble gp91phox 221-C protein (Figure 3B).
###end p 45
###begin p 46
###xml 29 33 29 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 193 202 193 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g005">Figure 5B</xref>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Koshkin1">[22]</xref>
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Koshkin2">[23]</xref>
###xml 317 321 317 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 458 462 458 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 532 536 532 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 629 633 629 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 698 702 698 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 785 789 785 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 940 949 940 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g003">Figure 3B</xref>
###xml 976 980 976 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Interestingly, truncated gp91phox 221-C proteins integrated into natural lipid vesicles exhibit NADPH- and FAD-dependent activity that did not require the addition of cytosolic factors and AA (Figure 5B, without activation). As already described by Koshkin [22], [23], the phospholipid environment of relipidated gp91phox protein has a critical influence on its folding status and on its affinity to bind co-factors such as FAD, leading to a self-active gp91phox protein that only requires NADPH and FAD. This basal activity of gp91phox 221-C protein in the presence of the 2 co-factors was 7.8 mol of NBT reduced/min/mol of gp91phox 221-C proteoliposomes and 5.5 mol of INT reduced/min/mol of gp91phox 221-C proteoliposomes. These values were comparable to those obtained for the gp91phox 221-C protein expressed in the presence of detergent and activated by cytosolic factors and AA (6.1 and 7.2 mol/min/mol for NBT and INT respectively, Figure 3B). This means that the gp91phox 221-C protein embedded into natural lipids is folded in a more active conformation in comparison to the detergent-soluble protein.
###end p 46
###begin p 47
###xml 34 38 34 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 130 134 130 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 139 143 139 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 148 152 148 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 308 317 302 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g005">Figure 5B</xref>
###xml 405 409 399 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
When 10 pmoles of recombinant gp91phox 221-C proteoliposomes were incubated for 10 minutes with neutrophil cytosol (containing p47phox, p67phox, p40phox and Rac) and AA at 25degreesC, reductase activity was enhanced by a seven fold increase for NBT and ten fold for INT (53 mol/min/mol for both NBT and INT, Figure 5B activated). Taken together, these results confirmed that the recombinant truncated gp91phox 221-C protein was able to display a partial diaphorase activity when embedded into natural lipids and an increased activity after activation by cytosolic partners and AA.
###end p 47
###begin title 48
###xml 43 47 43 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Transduction of active proteoliposomes gp91phox 221-C into living cells
###end title 48
###begin p 49
###xml 78 82 78 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 167 171 167 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 108 113 <span type="species:ncbi:9606">human</span>
To test the capacity of the recombinant proteoliposomes to deliver active gp91phox 221-C protein, we used a human carcinoma cell line HCT116 which is negative for gp91phox messenger and proteins (data not shown).
###end p 49
###begin p 50
###xml 34 38 34 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 102 106 102 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 206 215 206 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g005">Figure 5C</xref>
###xml 264 268 264 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 369 378 369 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g005">Figure 5C</xref>
The cells were incubated with gp91phox 221-C proteoliposomes for 8 hours. The uptake of exogenous gp91phox 221-C protein by the cells was detected by imunocytochemistry staining using an anti-his antibody (Figure 5C). Only cells incubated with proteoliposomes gp91phox 221-C were positive for imunocytochemistry staining with a punctuated signal surrounding the cells (Figure 5C).
###end p 50
###begin p 51
###xml 57 61 57 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 168 172 168 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 250 254 250 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 311 315 311 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 373 377 373 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 467 471 467 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 623 632 623 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g005">Figure 5D</xref>
###xml 830 834 830 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 971 979 971 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g005">Figure 5</xref>
###xml 1056 1060 1056 1060 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1205 1214 1205 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g005">Figure 5D</xref>
###xml 1216 1220 1216 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Rentsendorj1">[24]</xref>
To confirm the cellular integration of the exogenous gp91phox 221-C protein into the plasma membrane a set of experiments has been performed using freshly produced gp91phox 221-C proteoliposomes. HeLa cells were incubated for 8 hours either with gp91phox 221-C proteoliposomes or empty liposomes or soluble gp91phox 221-C. The subcellular localization of the exogenous gp91phox 221-C protein in the cells was detected by imunocytochemistry staining using an anti-gp91phox antibody (54.1, in red) and an anti-Clathrin light chain subunits (sc-28276, in green). After fixation, cells were analyzed using confocal microscopy (Figure 5D). Cells incubated with the soluble protein were permeabilized or not with saponin to check for possible external binding. A red punctuated signal can be observed only with cells incubated with gp91phox 221-C proteoliposomes illustrating that our results are reproducible and that the delivery is specifically due to the liposome carrier (Figure 5 C and 5D). Furthermore, the orthogonal sections show that the exogenous gp91phox 221-C protein is localized into the same z sections as the clathrin clearly indicating that the protein is integrated into the plasma membrane (Figure 5D, [24]).
###end p 51
###begin p 52
The use of liposomes as a delivery tool allowed the release of active membrane protein directly into the plasma membrane of cells.
###end p 52
###begin title 53
###xml 24 28 24 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Diaphorase assay of gp91phox 90-N proteoliposomes
###end title 53
###begin p 54
###xml 122 126 122 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 156 160 156 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 279 283 279 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 290 299 290 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g005">Figure 5A</xref>
In order to improve the system of production of mammalian membrane proteins and to further explore the effects of the gp91phox protein, we produced the gp91phox 90-N protein which contains 4 transmembrane domains in the presence of natural liposomes. As previously found for gp91phox 90-N (Figure 5A), the optimal amount of lipids required for its synthesis was 2.5mg/ml.
###end p 54
###begin p 55
###xml 30 34 30 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 59 63 59 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 172 181 172 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g006">Figure 6A</xref>
###xml 328 332 328 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 356 365 356 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g005">Figure 5B</xref>
###xml 454 458 454 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 607 616 607 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g006">Figure 6A</xref>
###xml 675 679 675 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 754 764 754 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g005">Figures 5B</xref>
###xml 769 771 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g006">6A</xref>
Interestingly, as for the gp91phox 221-C proteins, the gp91phox 90-N proteins embedded into natural lipid exhibited an intrinsic activity without cytosolic factors and AA (Figure 6A, without activation, 13.5 mol/min/mol for NBT reduction and 14 mol/min/mol for INT reduction). These values were slightly higher than for the gp91phox 221-C proteoliposomes (Figure 5B), but the addition of cytosolic extract and AA enhanced the activity of recombinant gp91phox 90-N to the similar values of gp91phox 221-C proteoliposomes, indicating a fully active enzyme (54 and 53 mol/min/mol for NBT and INT respectively, Figure 6A). Embedded into natural lipids, recombinant truncated gp91phox proteins displayed basal activity and a maximum turnover upon activation (Figures 5B and 6A).
###end p 55
###begin title 56
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
gp91phox 90-N proteoliposomes.
###end title 56
###begin p 57
###xml 132 136 130 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 351 355 349 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
(A) Diaphorase assay of purified proteoliposomes gp91phox 90-N using NBT or INT as electron acceptor, n>/=2. Cellular uptake of gp91phox 90-N proteins delivered with proteoliposomes in HeLa cells after 8 or 24 hours of incubation. The proteins were detected by fluorescence microscopy using a monoclonal anti-his antibody (B) or a monoclonal anti-gp91phox antibody (C).
###end p 57
###begin title 58
###xml 43 47 43 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Transduction of active proteoliposomes gp91phox 90-N into living cells
###end title 58
###begin p 59
###xml 166 170 166 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 109 114 <span type="species:ncbi:9606">human</span>
In order to examine the delivery of active mammalian membrane protein using liposomes as carriers, we used a human carcinoma cell line HeLa which is negative for gp91phox proteins (data not shown) so as to exclude cellular specificity of the delivery.
###end p 59
###begin p 60
###xml 139 143 139 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 250 259 250 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g006">Figure 6B</xref>
###xml 276 280 276 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 291 300 291 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g006">Figure 6C</xref>
###xml 347 351 347 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 442 459 442 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g006">Figures 6B and 6C</xref>
###xml 501 505 501 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 516 525 516 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g006">Figure 6C</xref>
###xml 590 594 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Baniulis1">[25]</xref>
###xml 697 714 697 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g006">Figures 6B and 6C</xref>
###xml 738 742 738 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 861 878 861 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g006">Figures 6B and 6C</xref>
To improve this delivery system and to follow the destiny of exogenous protein, we observed the subcellular distribution of transduced gp91phox 90-N protein in HeLa cells after 8 and 24 hours by immunocytochemistry using either an anti-his antibody (Figure 6B) or an anti-gp91phox antibody (Figure 6C). Interestingly, the cells incubated with gp91phox 90-N proteoliposomes were positive for immunocytochemistry staining with both antibodies (Figures 6B and 6C). The higher background for the anti-gp91phox antibody (Figure 6C) could be explained by its cross-reactivity with GRP 58 protein [25]. After 8 hours, the punctuated signal surrounding the cells indicated a plasma membrane localization (Figures 6B and 6C) for the delivered gp91phox 90-N proteins and after 24 hours, the proteins remained detectable and localized to the plasma membrane of the cells (Figures 6B and 6C).
###end p 60
###begin p 61
###xml 171 185 171 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g005">Figures 5C, 5D</xref>
###xml 187 196 187 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g006">6B and 6C</xref>
The delivery of recombinant mammalian membrane proteins into living cells using liposomes as a vector appears to be a powerful system in the targeting of deficient cells (Figures 5C, 5D, 6B and 6C).
###end p 61
###begin title 62
Discussion
###end title 62
###begin p 63
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Grisshammer1">[26]</xref>
###xml 773 777 773 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Monne1">[27]</xref>
###xml 778 782 778 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Jidenko1">[30]</xref>
###xml 1069 1076 1069 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1101 1105 1101 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Liguori1">[13]</xref>
###xml 1181 1188 1181 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1188 1192 1188 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Klammt1">[14]</xref>
###xml 1194 1198 1194 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Berrier1">[31]</xref>
###xml 1200 1204 1200 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Elbaz1">[32]</xref>
###xml 1232 1236 1232 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Klammt2">[15]</xref>
###xml 1238 1242 1238 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Ishihara1">[16]</xref>
###xml 1181 1188 <span type="species:ncbi:562">E. coli</span>
The study of functional membrane proteins remains a challenging task, regardless of the fact that important progress has recently been made in the isolation of eukaryotic membrane proteins from natural sources or the production of membrane proteins in heterologous expression systems [26]. The failure to produce recombinant eukaryotic membrane proteins is mainly due to a misfolding and rapid degradation of the over-expressed membrane proteins. Moreover, low yields and cellular toxicity can account for the difficulty in producing membrane proteins. Recent studies on the synthesis of mammalian membrane proteins in different optimized expression systems have been explored in order to produce large amounts of recombinant proteins for functional and structural studies [27]-[30]. However, expression in these systems often results in the targeting of the membrane proteins to the inclusion bodies or to the membrane of the host cells, thus rendering their subsequent study difficult. Cell-free expression systems represent an excellent alternative to the classical in vivo over-expression systems [13]. These have already been used for the production of membrane proteins from E. coli[14], [31], [32] or from eukaryotic sources [15], [16].
###end p 63
###begin p 64
###xml 8 12 8 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 105 108 105 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
###xml 104 108 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b<sub>558</sub></italic>
###xml 180 184 180 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 337 338 337 338 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 338 339 338 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 513 517 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Taylor2">[17]</xref>
###xml 519 523 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Campion1">[33]</xref>
###xml 584 587 584 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Paclet1">[7]</xref>
###xml 589 593 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Berthier1">[34]</xref>
###xml 644 648 644 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 657 660 657 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Nisimoto1">[6]</xref>
###xml 662 666 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Pessach1">[35]</xref>
###xml 680 684 680 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 693 696 693 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Zhu1">[8]</xref>
###xml 845 849 845 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Berthier1">[34]</xref>
###xml 918 921 918 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Zhu1">[8]</xref>
###xml 967 971 967 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 971 975 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Campion1">[33]</xref>
###xml 1050 1054 1050 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Taylor2">[17]</xref>
The gp91phox protein is a transmembrane glycosylated hemoprotein. It is the redox-subunit of cytochrome b558 and the catalytic core of the phagocyte NADPH oxidase. The lack of gp91phox causes an X-linked chronic granulomatous disease (CGD), a rare genetic disorder characterized by severe and recurrent infections due to the failure of O2--generating NADPH oxidase and the absence of reactive oxygen species. Different approaches have been used to study the NADPH oxidase complex, including monoclonal antibodies [17], [33], isolation and purification of the complex from neutrophils [7], [34] and the expression of deletion mutants of the gp91phox protein [6], [35] or of the p22phox protein [8]. These methods have provided vital information about the regulation of this enzymatic complex through the identification of new regulatory proteins [34], the description of domains of interaction between its two subunits [8], the modification of the conformation of gp91phox[33] and topological information regarding the components of the NADPH complex [17].
###end p 64
###begin p 65
###xml 98 102 98 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 154 171 154 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g002">Figures 2A and 2B</xref>
###xml 203 207 203 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 337 341 337 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 486 489 486 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Nisimoto1">[6]</xref>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Han1">[36]</xref>
###xml 622 626 622 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 676 680 676 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 696 699 696 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Mizrahi1">[5]</xref>
###xml 736 740 736 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 775 779 775 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 811 820 811 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g003">Figure 3B</xref>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g004">4B</xref>
###xml 898 902 898 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 941 947 941 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 947 950 947 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Nisimoto1">[6]</xref>
###xml 1017 1021 1017 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</italic>
###xml 1077 1081 1077 1081 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1230 1234 1230 1234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 941 947 <span type="species:ncbi:562">E.coli</span>
In this study we have developed a new method for producing fully active recombinant truncated gp91phox proteins containing up to 4 transmembrane domains (Figures 2A and 2B). We show that recombinant gp91phox proteins are solubilized by non-ionic or zwitterionic detergents and that they exhibit reductase activities in the absence of p22phox protein. Recent studies reported that the C-terminal part of the protein (aa 221 to 570) is responsible for electron transfer from NADPH to FAD [6], [36]. However, stimulation of the reductase activities of these constructs appears to depend either on the activation domain of p67phox and Rac or on the carboxyl-terminal truncated p67phox fused with Rac [5]. Our finding shows that soluble gp91phox 221-C displays an NADPH- and a p67phox-dependent diaphorase activity (Figure 3B and 4B) identical to that described by Nisimoto using truncated forms of gp91phox over-expressed as inclusion bodies in E.coli[6]. These data confirm the specific role of the cytosolic regulatory phox factors in the electron transfer activation in the gp91phox truncated form and led us to conclude that our optimized cell-free expression system represents a new alternative to obtaining active truncated gp91phox recombinant derivatives.
###end p 65
###begin p 66
###xml 156 160 156 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Paclet2">[19]</xref>
###xml 325 328 325 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
###xml 324 328 324 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b<sub>558</sub></italic>
Our recombinant model also supports previous works reporting that N-glycosylation on three Asn residues [Asn132, Asn149 and Asn240; 4] of the wild type gp91phox protein are not required for the production of superoxide anions [19]. Although we cannot exclude the possibility that glycosylation may be involved in cytochrome b558 stability in neutrophils, all the recombinant proteins produced by the cell-free expression system are not glycosylated, but display diaphorase activities.
###end p 66
###begin p 67
###xml 161 165 161 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 279 283 279 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 291 295 291 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 350 353 350 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
###xml 349 353 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b<sub>558</sub></italic>
###xml 510 514 510 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 555 559 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Bedard1">[37]</xref>
Taken together, these results demonstrate that our optimized cell-free expression system represents a new alternative for the generation of active truncated gp91phox proteins. These derivatives could be used as molecular probes to further investigate the interaction between gp91phox and p22phox and the subsequent conformation states of cytochrome b558 at rest and upon activation of NADPH oxidase. Furthermore, this original recombinant approach will be used to study the recently discovered isoforms of gp91phox, mainly Nox1 and Nox4 of the Nox family [37].
###end p 67
###begin p 68
###xml 94 97 94 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b<sub>558</sub></italic>
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Koshkin1">[22]</xref>
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Koshkin2">[23]</xref>
###xml 567 571 567 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 631 636 631 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 670 674 670 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 841 845 841 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 904 908 904 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 958 962 958 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1164 1168 1164 1168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1256 1260 1256 1260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1406 1410 1406 1410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1508 1512 1508 1512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Previous studies of Koshkin and Pick showed an intrinsic activity of the purified cytochrome b558 from neutrophils after integration into lipids without the requirement of any activation [22], [23], implying that the lipid environment plays a crucial role in the activity and the conformation of proteins. An interesting feature of the cell-free expression system is its compatibility with natural lipid vesicles. We have demonstrated that the addition of liposomes into the reaction mixture allows direct formation of active proteoliposomes containing truncated gp91phox protein or membrane proteins from various origins (Liguori et al., submitted). We showed that gp91phox 221-C proteoliposomes display similar diaphorase activity as the soluble protein, even in absence of cytosolic factors or anionic amphiphile (7.8 mol/min/mol for gp91phox 221-C proteoliposomes and 6.1 mol/min/mol for soluble gp91phox 221-C). Moreover, the diaphorase activity of gp91phox 221-C proteoliposomes can be enhanced 7 to 10 fold by the addition of cytosolic partners and AA, leading to a better activation of the protein. Furthermore, similar results have been obtained with gp91phox 90-N proteoliposomes. These results suggest a "native-like" conformation for these gp91phox constructs that was directly dependent on the lipid environment. This, to our knowledge, is the first demonstration of an active recombinant gp91phox protein with four transmembrane domains directly integrated into lipids in the absence of the p22phox protein.
###end p 68
###begin p 69
###xml 198 201 198 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
###xml 197 201 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b<sub>558</sub></italic>
###xml 251 254 251 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Paclet1">[7]</xref>
###xml 280 284 280 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 342 345 342 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
###xml 341 354 341 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b<sub>558</sub> in vitro</italic>
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Sarfstein1">[38]</xref>
###xml 586 590 586 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 769 773 769 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Recently, a fully active NADPH oxidase complex was isolated onto an affinity matrix and in the absence of lipids. The constitutive activity of the isolated complex suggested a change of cytochrome b558 conformation from an inactive to an active state [7]. Moreover, prenylated p67phox-rac1 chimera were shown to activate membrane cytochrome b558 in vitro in the absence of lipids or amphiphil reagent [38]. However, our findings point to the development of a recombinant model of neutrophil-like NADPH oxidase which allows the direct production of active and "native-like" membrane gp91phox that is qualitatively similar to that of purified protein from neutrophils. Further structural data will shed light on the mechanisms of diaphorase activation of recombinant gp91phox constructs in the absence or presence of lipids.
###end p 69
###begin p 70
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Park1">[11]</xref>
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Cusi1">[39]</xref>
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Kim1">[40]</xref>
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Wasan1">[41]</xref>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Sengupta1">[42]</xref>
###xml 618 625 618 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 733 737 733 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Torchilin1">[43]</xref>
Data presented here provide conclusive results on the capacity of the optimized cell-free expression system to produce fully active proteoliposomes in a one-step reaction. Liposomes are now widely used for the delivery of various therapeutic molecules such as antibodies [11], nucleic acids [39], peptides [40] and antifungal [41] or anticancer drugs [42]. These molecules can be located either in the aqueous compartment, if soluble, or embedded into the bilayer for hydrophobic compounds. Moreover, various liposomal vesicles containing pharmaceutical agents have been developed to sustain their therapeutic actions in vivo by a prolonged half-life circulation, a reduced cytotoxicity and an improved cellular and tissue targeting [43].
###end p 70
###begin p 71
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Ott1">[10]</xref>
###xml 561 565 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Boeckle1">[44]</xref>
One of the current challenges in therapy is to develop new strategies in the efficient treatment of disease. Encouraging results have recently been obtained using gene therapy to treat CGD [10]. However, even if gene therapy appears to be a promising method of treatment of rare diseases, its efficiency needs to be improved, and a number of major problems inherent to this technology remain to be solved, such as immunogenic responses against the vector, low specificity of cells expressing the protein and the random insertion of DNA into the genome of cells [44]. Therefore, an alternative or a complementary approach to gene therapy needs to be developed.
###end p 71
###begin p 72
###xml 329 337 329 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 346 356 346 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g005">Figures 5B</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g006">6A</xref>
###xml 406 410 406 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 463 477 463 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g005">Figures 5C, 5D</xref>
###xml 479 488 479 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000856-g006">6B and 6C</xref>
###xml 837 838 837 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 838 842 838 842 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558 </sub>
###xml 1283 1284 1279 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 1284 1287 1280 1283 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
In this paper, we report the development of a new method to produce recombinant proteoliposomes containing membrane protein in a one-step reaction, and we demonstrate that these proteoliposomes can be used as carriers for delivering membrane proteins. We evaluate the ability of proteoliposomes to exhibit diaphorase activity in in vitro assays (Figures 5B and 6A) and to efficiently deliver truncated gp91phox protein into cells targeting their plasma membrane (Figures 5C, 5D, 6B and 6C). Therefore, we demonstrated the "proof of concept" that the active embedded protein can be directly delivered to the plasma membrane of different cell lines, and we demonstrated that our proteoliposomes may represent an original approach for protein therapy. However, production by the cell-free expression system of a fully functional cytochrome b558 containing two hemes remains a challenge. The incorporation of hemin in the cell-free expression medium was first tested to evaluate the feasibility to express heme-bound protein with this expression system. Preliminary results indicate that concentrations of hemin below 1.6 microM do not interfere with the transcription/translation process suggesting that the cell-free expression system could be useful to produce recombinant cytochrome b558.
###end p 72
###begin title 73
Materials and Methods
###end title 73
###begin title 74
Materials
###end title 74
###begin p 75
All the chemicals were from Sigma-Aldrich and the detergents from Calbiochem. Medium for cell culture were from Invitrogen-Gibco.
###end p 75
###begin title 76
###xml 14 18 14 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Truncated gp91phox
###end title 76
###begin p 77
###xml 30 34 30 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 78 80 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5&#8242;</sup>
###xml 87 93 87 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CATATG</bold>
###xml 114 116 114 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3&#8242;</sup>
###xml 125 129 125 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 134 136 134 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5&#8242;</sup>
###xml 143 149 143 149 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CATATG</bold>
###xml 170 172 170 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3&#8242;</sup>
###xml 181 185 181 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 191 193 191 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5&#8242;</sup>
###xml 200 206 200 206 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CATATG</bold>
###xml 225 227 225 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3&#8242;</sup>
###xml 236 240 236 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 246 248 246 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5&#8242;</sup>
###xml 255 261 255 261 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CATATG</bold>
###xml 279 281 279 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3&#8242;</sup>
###xml 290 294 290 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 303 305 303 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5&#8242;</sup>
###xml 312 318 312 318 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CATATG</bold>
###xml 337 339 337 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3&#8242;</sup>
###xml 348 352 348 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 439 441 439 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5&#8242;</sup>
###xml 447 453 447 453 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCGAG</bold>
###xml 469 472 469 472 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TTA</underline>
###xml 476 478 476 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3&#8242;</sup>
###xml 525 527 525 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5&#8242;</sup>
###xml 533 539 533 539 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCGAG</bold>
###xml 561 563 561 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3&#8242;</sup>
###xml 759 763 759 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
The different versions of gp91phox were obtained by PCR. The forward primers (5'GGAATTCCATATGGTTCGAAGACAACTGGACAGG3' for gp91phox 90, 5'GGAATTCCATATGAAAACCATCCGGAGGTCTTAC3' for gp91phox 195, 5'GGAATTCCATATGATCCATGGAGCTGAACGAA3' for gp91phox 221, 5'GGAATTCCATATGGCAGAGAGTTTGGCTGTG3' for gp91phox 233 and 5'GGAATTCCATATGTTTTGGCGATCTCAACAGA3' for gp91phox 285) were designed to introduce a NdeI site (shown in boldface). The reverse primers (5'GCGTTACTCGAGTCATGGAAGAGACAAGTTAGAAG3' for the N-terminal position of the his-tag or 5'GCGTTACTCGAGGAAGTTTTCCTTGTTGAAAATG3' for the C-terminal position of the his-tag) were designed to introduce a XhoI site (shown in boldface) and a stop codon for the N-terminal position of the his-tag (underlined). The truncated gp91phox were directly cloned in pIVEX 2.3MCS and in pIVEX 2.4NdeI vectors (Roche Applied Science).
###end p 77
###begin title 78
###xml 28 32 28 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Cell-free expression of gp91phox
###end title 78
###begin p 79
###xml 335 336 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 384 385 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 432 433 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 655 656 634 635 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Expression test for each protein was performed using the RTStrade mark HY100 (Roche Applied Science) according to the manufacturer's instructions. We tested different compounds to enhance the expression under soluble form (i.e. "native-like" conformation): GroE chaperone, GSH/GSSG (0.01 mM/0.4 mM), Nonidet P40 (NP40, 5 mM), beta-OG (n-Octyl-beta-D-glucopyranoside, 25 mM), Thio-OG (n-Octyl-beta-D-thioglycopyranoside, 9 mM), DDM (n-Dodecyl-beta-D-maltoside, 0,1 mM), CHAPS (3-[(3-cholamidopropyl)-dimethylammonio]propanesulfonate, 10 mM) or liposomes at different concentration (from 1 mg/ml up to 5 mg/ml). Liposomes are obtained by evaporation of CHCl3/MeOH from the lipid preparation (SpeedVac System, Thermo Savant) and resuspension of the lipids in DEPC water. Sonication (3 times for 1 minute on ice, Branson Sonic power, Smithkline Company Brentford, Middlesex, UK) and filtration through a 0.22 microm filter leads to liposomes constitution. The reactions were performed during 15 h at 30degreesC with 180rpm shaking in the Proteomastertrade mark (Roche Applied Science). The solubility was assayed by centrifugation (30 minutes, 21400 g, 4degreesC) using a Sigma 2K15 centrifuge. The supernatant was considered as the soluble fraction (except when expressed with liposomes) and the solubility was evaluated by densitometry analysis of the western blot using ImageJ programme (NIH, USA). For scale-up experiments, RTStrade mark HY500 ProteoMaster from Roche Applied Science was used during 48 hours at 20degreesC with 990rpm shaking.
###end p 79
###begin title 80
Purification of the soluble proteins by IMAC
###end title 80
###begin p 81
The soluble fraction of the reaction was equilibrated by the addition of 4 column volumes (CV) of buffer A (Na-phosphate 50 mM pH 7+500 mM NaCl+Glycerol 15%+DDM 0,1 mM+Complet EDTA free) and then loaded, at least 10 times, onto a column containing 500 microl of Talontrade mark resin (BD Biosciences Clonetech), pre-equilibrated with 20 CV of buffer A. The column was then washed extensively with 20 CV of buffer A+10 mM imidazol. The protein was eluted with 4 CV of buffer A+250 mM imidazol.
###end p 81
###begin title 82
Proteoliposomes purification
###end title 82
###begin p 83
After production, the mixtures are centrifuged at 13000 g, 20 min at 4degreesC, the supernatant discarded and the pellet resuspended in 1 ml Tris 50 mM, pH 7.2. The resuspended pellet was loaded on a 3 steps discontinuous sucrose gradient (60%, 25% and 10%) prepared in Tris 50 mM, pH 7.2. The sample is loaded between 60% layer (6 ml) and 25% layer (6 ml). 2 ml of 10% sucrose fulfils the gradient. After ultracentrifugation (1 hour at 200000g at 4degreesC), fractions of 1 ml were collected until the bottom of the gradient and analyzed by western blotting and silver staining.
###end p 83
###begin title 84
Lymphoid Cell Line and Neutrophils
###end title 84
###begin p 85
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 245 248 245 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Paclet1">[7]</xref>
###xml 386 389 386 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Paclet1">[7]</xref>
###xml 655 658 645 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Paclet1">[7]</xref>
###xml 755 758 745 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Paclet1">[7]</xref>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 77 84 <span type="species:ncbi:9606">patient</span>
###xml 337 355 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 357 360 <span type="species:ncbi:10376">EBV</span>
###xml 395 398 <span type="species:ncbi:10376">EBV</span>
###xml 488 492 <span type="species:ncbi:9913">calf</span>
Citrate-sterile venous blood was drawn from either healthy patients or a CGD patient with previously characterized CGD AR p670 after informed consent. Neutrophils and B lymphocytes were isolated by Ficoll-Hypaque density gradient centrifugation [7]. Lymphocytes were collected at the Ficoll surface and infected with the B95-8 strain of Epstein-Barr virus (EBV) as described previously [7]. The EBV-B lymphocyte cell lines were kept in culture using RPMI 1640 supplemented with 10% fetal calf serum, 2 mM L-glutamine, and 2 microg/mL Ciflox, at 37degreesC under a 5% CO2 atmosphere. Neutrophils were collected in the pellet after red-cell hypotonic lysis [7]. Crude membrane and cytosol fractions from both cell types were prepared as reported previously [7].
###end p 85
###begin title 86
###xml 11 12 11 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 12 15 12 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
Cytochrome b558 purification
###end title 86
###begin p 87
###xml 11 12 11 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 12 15 12 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
###xml 60 62 60 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 156 160 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Paclet2">[19]</xref>
Cytochrome b558 was purified from the plasma membranes of 1010 PMA-stimulated neutrophils and relipidated with L-alpha-phosphatidylcholine II-S as reported [19].
###end p 87
###begin title 88
Diaphorase assay in cell-free system
###end title 88
###begin p 89
###xml 40 48 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000856-Li1">[45]</xref>
###xml 115 119 115 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 161 162 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 162 165 162 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">558</sub>
###xml 220 221 216 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 354 358 338 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 698 703 660 665 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">595nm</sub>
###xml 713 715 675 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 718 720 680 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 750 755 706 711 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">500nm</sub>
###xml 763 765 719 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 768 770 724 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 308 311 <span type="species:ncbi:10376">EBV</span>
Electron transfer activity was measured in vitro using previously described protocols [45]. Purified proteins (gp91phox truncated forms or neutrophil cytochrome b558), 10 pmoles, were incubated with FAD (10 microM), MgCl2 (5 mM), GTPgammas (40 microM), 300 microg of cytosol from either human neutrophils or EBV-B lymphocytes (control or deficient in p67phox), and an optimum amount of AA (20 mM in EtOH) in PBS. After incubation for 10 min at 25degreesC, the reaction was initiated by the addition of NADPH (15 microM) in the presence of NBT (NitroBlue Tetrazolium) or INT (IodoNitro Tetrazolium) and the reduction of these compounds was followed during 30 minutes (at 595nm for NuBetaTau, epsilon595nm = 12.6 mM-1.cm-1 or at 500 nm for INT, epsilon500nm = 11 mM-1.cm-1). For the proteoliposomes, the assay was performed with or without sonication.
###end p 89
###begin title 90
Cell Culture
###end title 90
###begin p 91
###xml 351 355 351 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 387 391 387 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 445 446 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 93 99 <span type="species:ncbi:9913">bovine</span>
###xml 193 199 <span type="species:ncbi:9913">bovine</span>
HCT116 cells were cultured in McCoy's 5A medium supplemented with 10% heat-inactivated fetal bovine serum. HeLa cells were cultured in D-MEM medium supplemented with 10% heat-inactivated fetal bovine serum. For immunocytochemystry experiments, cells were cultured in eight-well slide chambers (Nalgen Nunc International) and treated with purified gp91phox proteoliposomes or soluble gp91phox protein at final concentration of 0.5 microg per 1x106 cells and incubated for 8 or 24 hours before imunocytochemistry.
###end p 91
###begin title 92
Imunocytochemistry
###end title 92
###begin p 93
###xml 574 578 <span type="species:ncbi:9925">goat</span>
###xml 584 589 <span type="species:ncbi:10090">mouse</span>
###xml 959 963 <span type="species:ncbi:9925">goat</span>
###xml 969 975 <span type="species:ncbi:9986">rabbit</span>
After incubation, cells were washed 2 times 5 minutes in PBS and fixed for 10 minutes in PFA 4% at 25degreesC. They were permeabilized 10 minutes in PBS, saponin 0.1% at 25degreesC, followed by 1 hour incubation at 25degreesC in blocking solution (PBS, 0.1% saponin, milk 5%) and over-night incubation at 4degreesC with primary monoclonal antibody (54.1 or anti-his, Euromedex clone 1DM-1H7) diluted at 1:1000 in blocking solution. After 3 washes in PBS for 5 minutes cells are incubated with a secondary antibody in blocking solution at 1:1000 during 1 hour at 25degreesC (goat anti-mouse Alexa-fluor 546, Molecular Probes). For confocal analysis, cells were incubated 5 hours at 25degreesC with Clathrin antibody (Clathrin LCA (H-55): sc-28276; Santa Cruz Biotechnology, Inc) diluted at 1:500 in blocking solution, washed 3 times in PBS for 5 minutes cells and incubated with a secondary antibody in blocking solution at 1:1000 during 1 hour at 25degreesC (goat anti-rabbit Alexa-fluor 488, Molecular Probes). Cells were washed 3 times 5 minute with PBS and nuclei were stained with Hoechst 33258 (1:2000) during 5 minutes at 25degreesC, washed again and then mounted. Samples were analyzed with an inverted Nikon Eclipse TE2000-E equipped with epifilters for the different fluorochromes using a 60x immersion objective or under a Zeiss LSM510 (NLO) laser confocal microscope.
###end p 93
###begin title 94
Supporting Information
###end title 94
###begin p 95
###xml 131 135 131 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 150 154 150 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 301 305 301 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 399 403 399 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 546 550 546 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 565 569 565 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 617 621 617 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Example of solubility after scale-up production detected by Coomassie blue staining and by western blotting. The solubility of gp91phox 285-N and gp91phox 221-C proteins was analyzed, after scale-up synthesis, by Coomassie blue staining and by western blotting using an anti-his antibody. For the gp91phox 285-N protein, 15% of the produced protein was found in the soluble fraction and for the gp91phox 221-C protein, 26% of the synthesized protein was recovered in the supernatant after centrifugation. The levels of solubilization for the gp91phox 195-N and gp91phox 233-N proteins were comparable to those of gp91phox 285-N (data not shown).
###end p 95
###begin p 96
(2.31 MB TIF)
###end p 96
###begin p 97
Click here for additional data file.
###end p 97
###begin p 98
We are grateful to Pr. A. J. Jesaitis (Dept of microbiology, Montana State University, Bozeman, USA.) for the generous gift of the monoclonal antibody 54.1, N. Roland for providing liposomes, O. Haddad for the confocal microscopy experiments and to G. Butt for correcting the final draft.
###end p 98
###begin title 99
References
###end title 99
###begin article-title 100
The superoxide-generating NADPH oxidase: structural aspects and activation mechanism.
###end article-title 100
###begin article-title 101
Assembly of the phagocyte NADPH oxidase.
###end article-title 101
###begin article-title 102
###xml 12 17 <span type="species:ncbi:9606">human</span>
Analysis of human phagocyte flavocytochrome b(558) by mass spectrometry.
###end article-title 102
###begin article-title 103
Analysis of glycosylation sites on gp91phox, the flavocytochrome of the NADPH oxidase, by site-directed mutagenesis and translation in vitro.
###end article-title 103
###begin article-title 104
Assembly of the phagocyte NADPH oxidase complex: chimeric constructs derived from the cytosolic components as tools for exploring structure-function relationships.
###end article-title 104
###begin article-title 105
Activation of the flavoprotein domain of gp91phox upon interaction with N-terminal p67phox (1-210) and the Rac complex.
###end article-title 105
###begin article-title 106
Regulation of phagocyte NADPH oxidase activity: identification of two cytochrome b558 activation states.
###end article-title 106
###begin article-title 107
Deletion mutagenesis of p22phox subunit of flavocytochrome b558: Identification of regions critical for gp91phox maturation and NADPH oxidase activity.
###end article-title 107
###begin article-title 108
Chronic granulomatous disease.
###end article-title 108
###begin article-title 109
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.
###end article-title 109
###begin article-title 110
Tumor targeting using anti-her2 immunoliposomes.
###end article-title 110
###begin article-title 111
Membrane proteins: functional and structural studies using reconstituted proteoliposomes and 2-D crystals.
###end article-title 111
###begin article-title 112
Production of membrane proteins using cell-free expression systems.
###end article-title 112
###begin article-title 113
Cell-free expression as an emerging technique for the large scale production of integral membrane protein.
###end article-title 113
###begin article-title 114
Cell-free production of G protein-coupled receptors for functional and structural studies.
###end article-title 114
###begin article-title 115
Expression of G protein coupled receptors in a cell-free translational system using detergents and thioredoxin-fusion vectors.
###end article-title 115
###begin article-title 116
Site-specific inhibitors of NADPH oxidase activity and structural probes of flavocytochrome b: characterization of six monoclonal antibodies to the p22phox subunit.
###end article-title 116
###begin article-title 117
Production of recombinant cytochrome b558 allows reconstitution of the phagocyte NADPH oxidase solely from recombinant proteins.
###end article-title 117
###begin article-title 118
NADPH oxidase of Epstein-Barr-virus immortalized B lymphocytes. Effect of cytochrome b(558) glycosylation.
###end article-title 118
###begin article-title 119
###xml 36 41 <span type="species:ncbi:9606">human</span>
The superoxide-generating system of human neutrophils possesses a novel diaphorase activity. Evidence for distinct regulation of electron flow within NADPH oxidase by p67-phox and p47-phox.
###end article-title 119
###begin article-title 120
Exploration of the diaphorase activity of neutrophil NADPH oxidase.
###end article-title 120
###begin article-title 121
Generation of superoxide by purified and relipidated cytochrome b559 in the absence of cytosolic activators.
###end article-title 121
###begin article-title 122
Superoxide production by cytochrome b559. Mechanism of cytosol-independent activation.
###end article-title 122
###begin article-title 123
Typical and atypical trafficking pathways of Ad5 penton base recombinant protein: implications for gene transfer.
###end article-title 123
###begin article-title 124
Evaluation of two anti-gp91phox antibodies as immunoprobes for Nox family proteins: mAb 54.1 recognizes recombinant full-length Nox2, Nox3 and the C-terminal domains of Nox1-4 and cross-reacts with GRP 58.
###end article-title 124
###begin article-title 125
Understanding recombinant expression of membrane proteins.
###end article-title 125
###begin article-title 126
###xml 57 75 <span type="species:ncbi:1358">Lactococcus lactis</span>
Functional expression of eukaryotic membrane proteins in Lactococcus lactis.
###end article-title 126
###begin article-title 127
A simple strategy towards membrane protein purification and crystallization.
###end article-title 127
###begin article-title 128
Structural genomics on membrane proteins: comparison of more than 100 GPCRs in 3 expression systems.
###end article-title 128
###begin article-title 129
###xml 65 89 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Crystallization of a mammalian membrane protein overexpressed in Saccharomyces cerevisiae.
###end article-title 129
###begin article-title 130
Cell-free synthesis of a functional ion channel in the absence of a membrane and in the presence of detergent.
###end article-title 130
###begin article-title 131
In vitro synthesis of fully functional EmrE, a multidrug transporter, and study of its oligomeric state.
###end article-title 131
###begin article-title 132
New insights into the membrane topology of the phagocyte NADPH oxidase: Characterization of an anti-gp91-phox conformational monoclonal antibody.
###end article-title 132
###begin article-title 133
Changing the conformation state of cytochrome b558 initiates NADPH oxidase activation: MRP8/MRP14 regulation.
###end article-title 133
###begin article-title 134
The C-terminal flavin domain of gp91phox bound to plasma membranes of granulocyte-like X-CGD PLB-985 cells is sufficient to anchor cytosolic oxidase components and support NADPH oxidase-associated diaphorase activity independent of cytosolic phospholipase A2 regulation.
###end article-title 134
###begin article-title 135
Characterization of the flavoprotein domain of gp91phox which has NADPH diaphorase activity.
###end article-title 135
###begin article-title 136
NOX family NADPH oxidases: Not just in mammals.
###end article-title 136
###begin article-title 137
Dual role of Rac in the assembly of NADPH oxidase, tethering to the membrane and activation of p67phox: a study based on mutagenesis of p67phox-Rac1 chimeras.
###end article-title 137
###begin article-title 138
Efficient delivery of DNA to dendritic cells mediated by influenza virosomes.
###end article-title 138
###begin article-title 139
Pharmacodynamics of insulin in polyethylene glycol-coated liposomes.
###end article-title 139
###begin article-title 140
###xml 189 193 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 208 229 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet(R) and AmBisome(R) in combination with caspofungin to rats infected with Aspergillus fumigatus.
###end article-title 140
###begin article-title 141
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system.
###end article-title 141
###begin article-title 142
Recent approaches to intracellular delivery of drugs and DNA and organelle targeting.
###end article-title 142
###begin article-title 143
Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems.
###end article-title 143
###begin article-title 144
Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly.
###end article-title 144
###begin p 145
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 145
###begin p 146
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the 'Ministere de l'Enseignement superieur de la Recherche et Technologie', Paris, France; the 'UFR de Medecine, Universite Joseph Fourier', Grenoble, France; the 'Region Rh?'ne Alpes, programme Emergence 2003', France; the CGD Research Trust, UK; the 'Groupement des Entreprises Francaises dans la lutte contre le Cancer', delegation de Grenoble, the 'Delegation Regionale de la Recherche Clinique', CHU Grenoble, France and the Marie Curie Excellence Grant (EXT014320).
###end p 146

